IDXX logo

IDEXX Laboratories (IDXX) Revenue

Annual revenue:

$3.90B+$236.55M(+6.46%)
December 31, 2024

Summary

  • As of today (April 20, 2025), IDXX annual revenue is $3.90 billion, with the most recent change of +$236.55 million (+6.46%) on December 31, 2024.
  • During the last 3 years, IDXX annual revenue has risen by +$682.14 million (+21.22%).
  • IDXX annual revenue is now at all-time high.

Performance

IDXX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXincome statement metrics

Quarterly revenue:

$954.29M-$21.25M(-2.18%)
December 31, 2024

Summary

  • As of today (April 20, 2025), IDXX quarterly revenue is $954.29 million, with the most recent change of -$21.25 million (-2.18%) on December 31, 2024.
  • Over the past year, IDXX quarterly revenue has stayed the same.
  • IDXX quarterly revenue is now -4.91% below its all-time high of $1.00 billion, reached on June 30, 2024.

Performance

IDXX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXincome statement metrics

TTM revenue:

$3.90B+$52.69M(+1.37%)
December 31, 2024

Summary

  • As of today (April 20, 2025), IDXX TTM revenue is $3.90 billion, with the most recent change of +$52.69 million (+1.37%) on December 31, 2024.
  • Over the past year, IDXX TTM revenue has stayed the same.
  • IDXX TTM revenue is now at all-time high.

Performance

IDXX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIDXXincome statement metrics

IDXX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.5%0.0%0.0%
3 y3 years+21.2%0.0%0.0%
5 y5 years+61.9%0.0%0.0%

IDXX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+21.2%-4.9%+15.2%at high+19.0%
5 y5-yearat high+61.9%-4.9%+52.4%at high+58.6%
alltimeall timeat high>+9999.0%-4.9%>+9999.0%at high>+9999.0%

IDEXX Laboratories Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$3.90B(+6.5%)
$954.29M(-2.2%)
$3.90B(+1.4%)
Sep 2024
-
$975.54M(-2.8%)
$3.84B(+1.6%)
Jun 2024
-
$1.00B(+4.1%)
$3.78B(+1.6%)
Mar 2024
-
$964.10M(+6.9%)
$3.72B(+1.7%)
Dec 2023
$3.66B(+8.7%)
$901.60M(-1.5%)
$3.66B(+2.0%)
Sep 2023
-
$915.53M(-3.0%)
$3.59B(+2.1%)
Jun 2023
-
$943.63M(+4.8%)
$3.51B(+2.4%)
Mar 2023
-
$900.20M(+8.6%)
$3.43B(+1.9%)
Dec 2022
$3.37B(+4.7%)
$828.57M(-1.6%)
$3.37B(+0.8%)
Sep 2022
-
$841.66M(-2.2%)
$3.34B(+0.9%)
Jun 2022
-
$860.55M(+2.9%)
$3.31B(+1.1%)
Mar 2022
-
$836.55M(+4.4%)
$3.27B(+1.8%)
Dec 2021
$3.22B(+18.8%)
$801.09M(-1.2%)
$3.22B(+2.6%)
Sep 2021
-
$810.42M(-1.9%)
$3.14B(+2.9%)
Jun 2021
-
$826.14M(+6.2%)
$3.05B(+6.6%)
Mar 2021
-
$777.71M(+7.9%)
$2.86B(+5.6%)
Dec 2020
$2.71B(+12.5%)
$720.94M(-0.1%)
$2.71B(+4.5%)
Sep 2020
-
$721.79M(+13.2%)
$2.59B(+4.7%)
Jun 2020
-
$637.59M(+1.8%)
$2.47B(+0.7%)
Mar 2020
-
$626.34M(+3.5%)
$2.46B(+2.1%)
Dec 2019
$2.41B(+8.8%)
$605.45M(+0.0%)
$2.41B(+2.4%)
Sep 2019
-
$605.30M(-2.4%)
$2.35B(+2.6%)
Jun 2019
-
$620.10M(+7.6%)
$2.29B(+1.7%)
Mar 2019
-
$576.06M(+4.9%)
$2.25B(+1.7%)
Dec 2018
$2.21B(+12.4%)
$549.39M(+0.7%)
$2.21B(+2.0%)
Sep 2018
-
$545.45M(-6.1%)
$2.17B(+2.5%)
Jun 2018
-
$580.75M(+8.0%)
$2.12B(+3.5%)
Mar 2018
-
$537.66M(+6.2%)
$2.04B(+3.8%)
Dec 2017
$1.97B(+10.9%)
$506.12M(+2.9%)
$1.97B(+3.3%)
Sep 2017
-
$491.98M(-3.3%)
$1.91B(+2.3%)
Jun 2017
-
$508.94M(+10.2%)
$1.86B(+2.3%)
Mar 2017
-
$462.02M(+4.3%)
$1.82B(+2.5%)
Dec 2016
$1.78B(+10.8%)
$443.00M(-1.2%)
$1.78B(+2.5%)
Sep 2016
-
$448.31M(-3.9%)
$1.73B(+2.5%)
Jun 2016
-
$466.57M(+11.7%)
$1.69B(+3.3%)
Mar 2016
-
$417.55M(+4.5%)
$1.64B(+2.2%)
Dec 2015
$1.60B(+7.8%)
$399.69M(-1.6%)
$1.60B(+3.1%)
Sep 2015
-
$406.39M(-1.7%)
$1.55B(+1.5%)
Jun 2015
-
$413.34M(+8.1%)
$1.53B(+1.5%)
Mar 2015
-
$382.48M(+8.7%)
$1.51B(+1.5%)
Dec 2014
$1.49B(+7.9%)
$351.96M(-8.2%)
$1.49B(-0.1%)
Sep 2014
-
$383.52M(-1.7%)
$1.49B(+3.1%)
Jun 2014
-
$390.12M(+8.3%)
$1.44B(+2.7%)
Mar 2014
-
$360.20M(+1.7%)
$1.41B(+2.0%)
Dec 2013
$1.38B(+6.5%)
$354.07M(+4.7%)
$1.38B(+2.6%)
Sep 2013
-
$338.30M(-4.1%)
$1.34B(+1.7%)
Jun 2013
-
$352.58M(+6.2%)
$1.32B(+1.3%)
Mar 2013
-
$332.11M(+3.9%)
$1.30B(+0.7%)
Dec 2012
$1.29B(+6.1%)
$319.54M(+1.3%)
$1.29B(+1.0%)
Sep 2012
-
$315.48M(-6.0%)
$1.28B(+1.1%)
Jun 2012
-
$335.65M(+4.0%)
$1.27B(+1.4%)
Mar 2012
-
$322.68M(+5.0%)
$1.25B(+2.5%)
Dec 2011
$1.22B(+10.4%)
$307.20M(+2.1%)
$1.22B(+2.0%)
Sep 2011
-
$300.95M(-5.3%)
$1.20B(+2.7%)
Jun 2011
-
$317.86M(+8.6%)
$1.16B(+3.2%)
Mar 2011
-
$292.67M(+3.1%)
$1.13B(+2.2%)
Dec 2010
$1.10B(+7.0%)
$283.76M(+5.2%)
$1.10B(+1.2%)
Sep 2010
-
$269.63M(-4.2%)
$1.09B(+1.0%)
Jun 2010
-
$281.48M(+4.8%)
$1.08B(+1.5%)
Mar 2010
-
$268.52M(-0.7%)
$1.06B(+3.1%)
Dec 2009
$1.03B(+0.7%)
$270.33M(+4.3%)
$1.03B(+2.7%)
Sep 2009
-
$259.12M(-2.5%)
$1.00B(+0.8%)
Jun 2009
-
$265.72M(+12.4%)
$996.56M(-1.5%)
Mar 2009
-
$236.46M(-2.8%)
$1.01B(-1.2%)
Dec 2008
$1.02B(+11.0%)
$243.29M(-3.1%)
$1.02B(-0.2%)
Sep 2008
-
$251.09M(-10.5%)
$1.03B(+2.2%)
Jun 2008
-
$280.57M(+12.6%)
$1.00B(+4.5%)
Mar 2008
-
$249.07M(+1.7%)
$960.47M(+4.1%)
DateAnnualQuarterlyTTM
Dec 2007
$922.55M(+24.8%)
$244.97M(+6.8%)
$922.55M(+6.1%)
Sep 2007
-
$229.38M(-3.2%)
$869.79M(+5.1%)
Jun 2007
-
$237.05M(+12.3%)
$827.79M(+5.8%)
Mar 2007
-
$211.16M(+9.9%)
$782.11M(+5.8%)
Dec 2006
$739.12M(+15.8%)
$192.21M(+2.6%)
$739.12M(+3.5%)
Sep 2006
-
$187.38M(-2.1%)
$713.88M(+4.3%)
Jun 2006
-
$191.36M(+13.8%)
$684.57M(+4.7%)
Mar 2006
-
$168.16M(+0.7%)
$653.83M(+2.5%)
Dec 2005
$638.10M(+16.2%)
$166.97M(+5.6%)
$638.10M(+3.7%)
Sep 2005
-
$158.07M(-1.6%)
$615.40M(+4.1%)
Jun 2005
-
$160.63M(+5.4%)
$591.44M(+4.1%)
Mar 2005
-
$152.43M(+5.7%)
$568.19M(+3.5%)
Dec 2004
$549.18M(+15.4%)
$144.27M(+7.6%)
$549.18M(+3.7%)
Sep 2004
-
$134.11M(-2.4%)
$529.75M(+2.7%)
Jun 2004
-
$137.38M(+3.0%)
$515.70M(+3.1%)
Mar 2004
-
$133.42M(+6.9%)
$500.16M(+5.1%)
Dec 2003
$475.99M(+15.3%)
$124.84M(+4.0%)
$475.99M(+4.1%)
Sep 2003
-
$120.06M(-1.5%)
$457.05M(+3.5%)
Jun 2003
-
$121.85M(+11.5%)
$441.52M(+3.8%)
Mar 2003
-
$109.25M(+3.2%)
$425.37M(+3.1%)
Dec 2002
$412.67M(+6.9%)
$105.89M(+1.3%)
$412.67M(+2.7%)
Sep 2002
-
$104.53M(-1.1%)
$401.91M(+1.8%)
Jun 2002
-
$105.69M(+9.5%)
$394.89M(+0.9%)
Mar 2002
-
$96.55M(+1.5%)
$391.21M(+1.3%)
Dec 2001
$386.08M(+5.1%)
$95.13M(-2.5%)
$386.08M(+0.7%)
Sep 2001
-
$97.52M(-4.4%)
$383.57M(+1.9%)
Jun 2001
-
$102.00M(+11.6%)
$376.43M(+2.3%)
Mar 2001
-
$91.43M(-1.3%)
$367.98M(+0.1%)
Dec 2000
$367.43M(+2.5%)
$92.62M(+2.5%)
$367.43M(+0.5%)
Sep 2000
-
$90.38M(-3.4%)
$365.61M(+1.1%)
Jun 2000
-
$93.55M(+2.9%)
$361.63M(+0.6%)
Mar 2000
-
$90.88M(+0.1%)
$359.58M(+0.4%)
Dec 1999
$358.40M(+12.0%)
$90.80M(+5.1%)
$358.30M(+2.3%)
Sep 1999
-
$86.40M(-5.6%)
$350.30M(+2.3%)
Jun 1999
-
$91.50M(+2.1%)
$342.40M(+3.2%)
Mar 1999
-
$89.60M(+8.2%)
$331.80M(+3.7%)
Dec 1998
$320.00M(+21.7%)
$82.80M(+5.5%)
$320.00M(+3.6%)
Sep 1998
-
$78.50M(-3.0%)
$309.00M(+2.3%)
Jun 1998
-
$80.90M(+4.0%)
$302.20M(+7.9%)
Mar 1998
-
$77.80M(+8.4%)
$280.20M(+6.6%)
Dec 1997
$263.00M(-1.8%)
$71.80M(+0.1%)
$262.90M(-1.1%)
Sep 1997
-
$71.70M(+21.7%)
$265.70M(+0.7%)
Jun 1997
-
$58.90M(-2.6%)
$263.80M(-2.6%)
Mar 1997
-
$60.50M(-18.9%)
$270.80M(+1.2%)
Dec 1996
$267.70M(+41.9%)
$74.60M(+6.9%)
$267.70M(+8.2%)
Sep 1996
-
$69.80M(+5.9%)
$247.30M(+9.3%)
Jun 1996
-
$65.90M(+14.8%)
$226.20M(+9.4%)
Mar 1996
-
$57.40M(+5.9%)
$206.80M(+9.7%)
Dec 1995
$188.60M(+49.2%)
$54.20M(+11.3%)
$188.60M(+10.7%)
Sep 1995
-
$48.70M(+4.7%)
$170.40M(+10.9%)
Jun 1995
-
$46.50M(+18.6%)
$153.60M(+11.1%)
Mar 1995
-
$39.20M(+8.9%)
$138.20M(+9.3%)
Dec 1994
$126.40M(+35.8%)
$36.00M(+12.9%)
$126.40M(+7.8%)
Sep 1994
-
$31.90M(+2.6%)
$117.20M(+7.4%)
Jun 1994
-
$31.10M(+13.5%)
$109.10M(+7.9%)
Mar 1994
-
$27.40M(+2.2%)
$101.10M(+8.5%)
Dec 1993
$93.10M(+61.4%)
$26.80M(+12.6%)
$93.20M(+12.6%)
Sep 1993
-
$23.80M(+3.0%)
$82.80M(+12.3%)
Jun 1993
-
$23.10M(+18.5%)
$73.70M(+12.7%)
Mar 1993
-
$19.50M(+18.9%)
$65.40M(+13.3%)
Dec 1992
$57.70M(+89.2%)
$16.40M(+11.6%)
$57.70M(+14.0%)
Sep 1992
-
$14.70M(-0.7%)
$50.60M(+16.6%)
Jun 1992
-
$14.80M(+25.4%)
$43.40M(+20.6%)
Mar 1992
-
$11.80M(+26.9%)
$36.00M(+18.0%)
Dec 1991
$30.50M
$9.30M(+24.0%)
$30.50M(+43.9%)
Sep 1991
-
$7.50M(+1.4%)
$21.20M(+54.7%)
Jun 1991
-
$7.40M(+17.5%)
$13.70M(+117.5%)
Mar 1991
-
$6.30M
$6.30M

FAQ

  • What is IDEXX Laboratories annual revenue?
  • What is the all time high annual revenue for IDEXX Laboratories?
  • What is IDEXX Laboratories annual revenue year-on-year change?
  • What is IDEXX Laboratories quarterly revenue?
  • What is the all time high quarterly revenue for IDEXX Laboratories?
  • What is IDEXX Laboratories quarterly revenue year-on-year change?
  • What is IDEXX Laboratories TTM revenue?
  • What is the all time high TTM revenue for IDEXX Laboratories?
  • What is IDEXX Laboratories TTM revenue year-on-year change?

What is IDEXX Laboratories annual revenue?

The current annual revenue of IDXX is $3.90B

What is the all time high annual revenue for IDEXX Laboratories?

IDEXX Laboratories all-time high annual revenue is $3.90B

What is IDEXX Laboratories annual revenue year-on-year change?

Over the past year, IDXX annual revenue has changed by +$236.55M (+6.46%)

What is IDEXX Laboratories quarterly revenue?

The current quarterly revenue of IDXX is $954.29M

What is the all time high quarterly revenue for IDEXX Laboratories?

IDEXX Laboratories all-time high quarterly revenue is $1.00B

What is IDEXX Laboratories quarterly revenue year-on-year change?

Over the past year, IDXX quarterly revenue has changed by $0.00 (0.00%)

What is IDEXX Laboratories TTM revenue?

The current TTM revenue of IDXX is $3.90B

What is the all time high TTM revenue for IDEXX Laboratories?

IDEXX Laboratories all-time high TTM revenue is $3.90B

What is IDEXX Laboratories TTM revenue year-on-year change?

Over the past year, IDXX TTM revenue has changed by $0.00 (0.00%)
On this page